中华脑血管病杂志(电子版)
中華腦血管病雜誌(電子版)
중화뇌혈관병잡지(전자판)
CHINESE JOURNAL OF CEREBROVASCULAR DISEASES(ELECTRONIC VERSION)
2008年
3期
194-197
,共4页
Zhen-Dong Cao%董佳容%A-Gao Zhou%沈仙娣
Zhen-Dong Cao%董佳容%A-Gao Zhou%瀋仙娣
Zhen-Dong Cao%동가용%A-Gao Zhou%침선제
养血清脑颗粒%盐酸氟西汀%卒中后抑郁
養血清腦顆粒%鹽痠氟西汀%卒中後抑鬱
양혈청뇌과립%염산불서정%졸중후억욱
Yangxueqingnao granule%fluoxetine hydrochloride%post-stroke Depression
目的:观察养血清脑颗粒联合盐酸氟西汀治疗卒中后抑郁的疗效.方法:68 例卒中后抑郁患者随机分组后分别接受养血清脑颗粒+盐酸氟西汀联合治疗(治疗组)和单纯盐酸氟西汀治疗(对照组),疗程为8 周;采用汉密尔顿抑郁量表(HAMD )进行评定.结果:在治疗8 周后,治疗组的显效率(48.7 %对47.1 %)和总有效率(79.4 %对76.5 %)与对照组相比均无显著差异,HAMD总评分和各项目评分也无显著差异.两组之间的睡眠障碍项目评分在第2 周时有显著差异(P<0.05 ),焦虑-抑郁情绪和躯体症状2 个项目评分在第2 周和第4 周均有显著差异(P<0.05 ).结论:养血清脑颗粒联合盐酸氟西汀治疗可改善卒中后抑郁的某些症状,优于单用盐酸氟西汀.
目的:觀察養血清腦顆粒聯閤鹽痠氟西汀治療卒中後抑鬱的療效.方法:68 例卒中後抑鬱患者隨機分組後分彆接受養血清腦顆粒+鹽痠氟西汀聯閤治療(治療組)和單純鹽痠氟西汀治療(對照組),療程為8 週;採用漢密爾頓抑鬱量錶(HAMD )進行評定.結果:在治療8 週後,治療組的顯效率(48.7 %對47.1 %)和總有效率(79.4 %對76.5 %)與對照組相比均無顯著差異,HAMD總評分和各項目評分也無顯著差異.兩組之間的睡眠障礙項目評分在第2 週時有顯著差異(P<0.05 ),焦慮-抑鬱情緒和軀體癥狀2 箇項目評分在第2 週和第4 週均有顯著差異(P<0.05 ).結論:養血清腦顆粒聯閤鹽痠氟西汀治療可改善卒中後抑鬱的某些癥狀,優于單用鹽痠氟西汀.
목적:관찰양혈청뇌과립연합염산불서정치료졸중후억욱적료효.방법:68 례졸중후억욱환자수궤분조후분별접수양혈청뇌과립+염산불서정연합치료(치료조)화단순염산불서정치료(대조조),료정위8 주;채용한밀이돈억욱량표(HAMD )진행평정.결과:재치료8 주후,치료조적현효솔(48.7 %대47.1 %)화총유효솔(79.4 %대76.5 %)여대조조상비균무현저차이,HAMD총평분화각항목평분야무현저차이.량조지간적수면장애항목평분재제2 주시유현저차이(P<0.05 ),초필-억욱정서화구체증상2 개항목평분재제2 주화제4 주균유현저차이(P<0.05 ).결론:양혈청뇌과립연합염산불서정치료가개선졸중후억욱적모사증상,우우단용염산불서정.
Objective: To observe the efficacy of Yangxueqingnao granule in combination with fluoxetine hydrochloride in the treatment of post-stroke depression (PSD). Methods: Sixty-eight patients with PSD were randomized to receive either Yangxueqingnao granule plus fluoxetine hydrochloride (treatment group) or fluoxetine hydrochloride alone (control group), and the duration of therapy was 8 weeks. The patients were evaluated with Hamilton Depression Scale (HAMD). Results: As compared with the control group, both the obvious effective rate (48.7 %versus 47.1 %) and total effective rate (79.4 %versus 76.5 %) after 8 weeks treatment in the treatment group had no significant differences. There were also no significant differences between the HAMD total score and each item score. There were significant differences in the item of sleep disorder score at week two between both groups (P<0.05); and there were significant differences between the item scores of anxiety-depression mood and somatic symptom at week 2 and 4 (P<0.05). Conclusions: Yangxueqingnao granule in combination with fluoxetine hydrochloride therapy may improve some symptoms of PSD, which is superior to fluoxetine hydrochloride alone.